Drug Profile
Research programme: pain therapeutics - PhytoPain Pharma
Alternative Names: PhytoPain Topical Gel Relief; PPTGRLatest Information Update: 28 Feb 2020
Price :
$50
*
At a glance
- Originator PhytoPain Pharma
- Class Analgesics; Cannabinoids; Small molecules
- Mechanism of Action Cannabinoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Neuropathic pain
Most Recent Events
- 28 Feb 2020 No recent reports of development identified for research development in Neuropathic-pain in Canada (Topical, Gel)
- 19 Mar 2018 Phytopain Pharma has been acquired by Tetra Bio-Pharma